BIO-Europe Spring 2026: In conversation with Marjorie SidHoum
Market Access
At BIO-Europe Spring in Lisbon, Portugal web editor Nicole Raleigh spoke with Marjorie SidHoum, vice president of business development & corporate communication at Kainova Therapeutics – a key player in the immuno-oncology and inflammation field.
SidHoum speaks to Kainova’s current pipeline, its recent financing led by Investissement Québec, and collaboration with major pharma, as well as physicians and KOLs.
Watch this and catch up on other exciting conversations from BIO-Europe Spring here.
